Dr. Hass was awarded a three year research grant in 2011 from the National Institutes of Health to develop a series of chemical compounds that could prove instrumental in limiting the harmful effects of the sun’s ultraviolet (UV) rays.
Research Description
Our lab works on the synthesis of novel co-drugs aimed at treating skin diseases, the development of stable topical formulations for these compounds, assessment of penetration and accumulation of topical experimental drugs in skin (using an ex vivo skin model) and evaluating efficacy using in vitro assays.
Positions
Professor (Pharmaceutical Sciences)
Albany College of Pharmacy and Health Sciences
1991
Education
PhD (Chemistry)
Rensselaer Polytechnic Institute
1988
BS (Chemistry)
University of Vermont
1983